SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 539 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,202,904 | +10.8% | 19,811 | +0.5% | 0.06% | +14.0% |
| Q2 2023 | $3,792,039 | +0.8% | 19,703 | +6.0% | 0.05% | -9.1% |
| Q1 2023 | $3,762,095 | +58.0% | 18,581 | +0.3% | 0.06% | +41.0% |
| Q4 2022 | $2,381,033 | +8.1% | 18,528 | +15.1% | 0.04% | -7.1% |
| Q3 2022 | $2,203,000 | -21.9% | 16,101 | +1.0% | 0.04% | -26.3% |
| Q2 2022 | $2,820,000 | +41.2% | 15,939 | +15.0% | 0.06% | +72.7% |
| Q1 2022 | $1,997,000 | -5.8% | 13,865 | +1.1% | 0.03% | 0.0% |
| Q4 2021 | $2,120,000 | -8.3% | 13,712 | +0.7% | 0.03% | -25.0% |
| Q3 2021 | $2,312,000 | +3.0% | 13,615 | -4.2% | 0.04% | +7.3% |
| Q2 2021 | $2,244,000 | +22.2% | 14,211 | +7.5% | 0.04% | +5.1% |
| Q1 2021 | $1,836,000 | -20.5% | 13,224 | +0.4% | 0.04% | -22.0% |
| Q4 2020 | $2,308,000 | – | 13,176 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |